methyltestosterone 1.25 MG
RxNorm concept 316289, clinical drug component (scdc).
- RxCUI
- 316289
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/316289 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet [Estratest] (SBD, constitutes)
- estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet (SCD, constitutes)
- estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet [Covaryx] (SBD, constitutes)
- methyltestosterone (IN, has ingredient)
- estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG [Estratest] (SBDC, has tradename)
- estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG [Covaryx] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 316289 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/316289 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 316289. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.